InVivo enrolls 9th patient in INSPIRE Study: 4 takeaways

Cambridge, Mass.-based InVivo Therapeutics enrolled a new patient in its INSPIRE Study, testing the Neuro-Spinal Scaffold’s efficacy and safety for complete thoracic AIS A spinal cord injury.

Advertisement

Here are four takeaways:

 

1. Oregon Health & Science University in Portland enrolled the patient.

 

2. Ahmed M. Raslan, MD, and Jason J Chang, MD, both assistant professors of neurological surgery and study investigators, implanted the Neuro-Spinal Scaffold in the patient about 36 hours post-injury.

 

3. The INSPIRE study now has nine enrolled patients.

 

4. The study involves 25 clinical sites across the country.

 

More articles on devices:
Wisconsin’s Comprehensive Orthopaedics launches YouTube channel: 3 thoughts
Kator launches suture anchor system on a limited basis: 3 key notes
Dr. Nasser Ani uses SpineFrontier’s new minimally-invasive technology: 4 things to know

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.